Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation
暂无分享,去创建一个
[1] J. Shanley,et al. IS CYTOMEGALOVIRUS INTERSTITIAL PNEUMONITIS IN TRANSPLANT RECIPIENTS AN IMMUNOPATHOLOGICAL CONDITION? , 1987, The Lancet.
[2] A. Levey,et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. , 1987, The New England journal of medicine.
[3] H. Balfour,et al. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. , 1987, JAMA.
[4] T. Creasy,et al. LIFE-THREATENING CYTOMEGALOVIRUS INFECTION TREATED WITH DIHYDROPROPOXYMETHYLGUANINE , 1986, The Lancet.
[5] D. Jeffries,et al. BWB759U, AN ANALOGUE OF ACYCLOVIR, INHIBITS HUMAN CYTOMEGALOVIRUS IN VITRO , 1984, The Lancet.
[6] J. Connor,et al. Treatment of cytomegalovirus pneumonia with high-dose acyclovir. , 1982, The American journal of medicine.
[7] H. Balfour,et al. A trial of vidarabine for cytomegalovirus infection in renal transplant patients. , 1980, Archives of internal medicine.
[8] H. Balfour,et al. Cytomegalovirus Disease in Renal Allograft Recipients: A Prospective Study of the Clinical Features, Risk Factors and Impact on Renal Transplantation , 1980, Medicine.
[9] C. Crumpacker,et al. Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia. , 1988, The Journal of infectious diseases.